Skip to main content Skip to footer Skip to navigation

Archives: 2021


News

US FDA Audit

TopChem has been audited remotely by the US Food and Drug Administration (FDA) and we are delighted to advise that we have successfully passed this latest inspection.
Written by TopChem Pharma
Published on

Zinc Sulfate

TopChem has shipped the first quantities of Zinc Sulfate suitable for use in injectable drug product formulations.
Written by TopChem Pharma
Published on

EU cGMP Audit

TopChem has successfully passed our fourth EU Current Good Manufacturing Practices (cGMP) audit, performed by the Health Products Regulatory Authority (HPRA).
Written by TopChem Pharma
Published on

US Patent for Bretylium Tosylate

Our recent US Patent 10836705 details our proprietary process for the manufacture of very high purity Bretylium Tosylate.
Written by TopChem Pharma
Published on

Launch of Bretylium Tosylate

TopChem collaborated with key partners to secure the US approval and relaunch of Bretylium Tosylate in the US market.
Written by TopChem Pharma
Published on
© TopChem Pharma